| Literature DB >> 35512008 |
Salma Javed1, JoAnn McClure2, Muhammad Ali Syed3, Osahon Obasuyi4, Shahzad Ali5, Sadia Tabassum1, Mohammad Ejaz3, Kunyan Zhang2,4,6,7,8.
Abstract
Buffalo represent a major source of milk in Pakistan. However, production is impacted by the disease bovine mastitis. Mastitis causes significant economic losses, with Staphylococcus aureus (S. aureus) being one of its major causative agents. While much work has been done understanding the epidemiology of bovine mastitis in Pakistan, detailed molecular characterization of the associated S. aureus is unavailable. In the current study both the epidemiological and molecular characterization of S. aureus from bovine mastitis in the Hazara division of Pakistan are examined. S. aureus was isolated from 18.41% of the animals, and left quarters more prone to infection (69.6%) than right quarters (30.4%). Sub-clinical mastitis (75.31%) was more prevalent than clinical mastitis (24.69%), with infections evenly distributed amongst the eight districts. Molecular characterization revealed that only 19.6% of the isolates were methicillin-resistant, and four strains types identified, including ST9-t7867-MSSA, ST9-MSSA, ST101-t2078-MSSA, and ST22-t8934-MRSA-IVa. Antiseptic resistance genes were not detected in the isolates, and low levels of antibiotic resistance were also noted, however the methicillin-resistant strains had higher overall antibiotic resistance. This study represents the most complete molecular typing data for S. aureus causing bovine mastitis in the Hazara district of Pakistan, and the country as a whole.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35512008 PMCID: PMC9071125 DOI: 10.1371/journal.pone.0268152
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.752
Summary of the S. aureus positive bovine mastitis infected quarters of buffaloes in Hazara division.
| No. |
|
| ||
|---|---|---|---|---|
| Right Front Quarter (a) | 16 | 15.69 | 16.69 | 0.000817 |
| Right Rear Quarter (b) | 15 | 14.71 | ||
| Left Front Quarter (c) | 35 | 34.31 | ||
| Left Rear Quarter (d) | 36 | 35.29 | ||
| 1 infected quarter | 61 | 75.31 | 122.95 | <0.00001 |
| 2 infected quarters | 19 | 23.46 | ||
| 3 infected quarters | 1 | 1.23 | ||
| 4 infected quarters | 1 | 1.23 | ||
Note: No., number of animals; %, percentage.
Details of clinical and sub-clinical bovine mastitis cases at the farm, animal and quarter level.
| Level | Overall | Overall Mastitis | Clinical Mastitis | Sub-Clinical Mastitis | |||
|---|---|---|---|---|---|---|---|
| No. | No. | % | No. | % | No. | % | |
| Farm | 88 | 62 | 70.45 | 20 | 32.26 | 52 | 83.87 |
| Animal | 440 | 81 | 18.41 | 20 | 24.69 | 61 | 75.31 |
| Quarter | 1760 | 102 | 5.80 | 32 | 31.37 | 70 | 68.63 |
Note: No., number; %, percentage.
District-wise details of the bovine mastitis clinical and sub-clinical cases in S. aureus infected animals.
| District | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Level | Mastitis |
|
|
|
|
| Kohistan | Kohistan |
| ||||||||
| No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | ||
| Animal | Overall | 12 | 14.81 | 10 | 12.35 | 13 | 16.05 | 10 | 12.35 | 12 | 14.81 | 14 | 17.28 | 8 | 9.88 | 2 | 2.47 |
| clinical | 4 | 20 | 3 | 15 | 2 | 10 | 2 | 10 | 3 | 15 | 3 | 15 | 2 | 10 | 1 | 5 | |
| sub-clinical | 8 | 13.11 | 7 | 11.8 | 11 | 18.03 | 8 | 13.11 | 9 | 14.75 | 11 | 18.03 | 6 | 9.84 | 1 | 1.64 | |
| Quarter | Overall | 17 | 16.67 | 15 | 14.71 | 15 | 14.71 | 12 | 11.76 | 14 | 13.73 | 17 | 16.67 | 10 | 9.80 | 2 | 1.96 |
| clinical | 8 | 25 | 6 | 18.76 | 3 | 9.38 | 3 | 9.38 | 4 | 12.5 | 5 | 15.63 | 2 | 6.25 | 1 | 3.13 | |
| sub-clinical | 9 | 12.86 | 9 | 12.86 | 12 | 17.14 | 9 | 12.86 | 10 | 14.29 | 12 | 17.14 | 8 | 11.43 | 1 | 1.43 | |
Note: No., number; %, percentage.
Analysis of the association between animal-level bovine mastitis and its various risk factors.
| Variables | Buffaloes | 95% CI |
| |
|---|---|---|---|---|
| No. Infected/ total | % | OR | ||
Note: No, Number; %, Percentage; OR, Odd ratio; CI, Confidence Interval. Binary logistic regression was used for two levels and multinomial logistic regression used for more than two levels variables.; χ2 (p-value), Chi-Square value (Pearson values for the variable groups as a whole); *, Significantly associated with the disease (p-value <0.05)
†, The variable is continuous therefore the values were calculate for the whole variable.
Overall molecular characteristics of the S. aureus isolated from bovine mastitis cases in the Hazara division.
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Isolate No. (%) | Type No. (%) | No. (%) | ST Type |
|
|
|
| |||
| MSSA 82 (80.4%) | 12 (14.6%) | ST101 | t2078 | I | - | 0 | 0 | 0 | 0 | |
| 25 (30.5%) | ST9 | t7286 | II | - | ||||||
| 45 (54.9) | ST9 | t7867 | II | - | ||||||
| MRSA 20 (19.6%) | 20 (100%) | ST22 | t8934 | I | IVa | |||||
Note: No., number; %, percentage; SCCmec, staphylococcal cassette chromosome mec; agr, accessory gene regulator; spa, staphylococcal protein A; ST, Staphylococcal type; qacA/B, multidrug efflux pump; smr, multidrug resistance protein family; mupA/B, mupirocin resistance A/B genes; -, negative
*, representing antiseptic resistance genes
†, representing antibiotic resistance genes.
Antibiotic resistance of the S. aureus from Hazara division.
| Antibiotic | Percentage Resistant | Percentage Intermediate Resistance | Percentage Sensitive |
|---|---|---|---|
| Ampicillin | 42.16 | 0 | 57.84 |
| Cefoxitin | 19.61 | 38.24 | 42.16 |
| Clindamycin | 0 | 12.75 | 87.25 |
| Gentamycin | 1.96 | 0 | 98.04 |
| Amoxicillin | 29.41 | 0 | 70.59 |
| Doxycycline | 2.94 | 0 | 97.06 |
| Lincomycin | 26.47 | 39.22 | 34.31 |
| Ceftazidime | 100 | 0 | 0 |
| Rifampin | 2.94 | 3.92 | 93.14 |
| TMP-SMX | 12.75 | 5.88 | 81.37 |
| Linezolid | 2.94 | 0.00 | 97.06 |
| Azithromycin | 7.84 | 10.79 | 81.37 |
| Ceftriaxone | 6.86 | 56.87 | 36.27 |
| Tetracycline | 5.88 | 3.92 | 90.2 |
| Norfloxacin | 0 | 1.96 | 98.04 |
| Erythromycin | 2.94 | 18.63 | 78.43 |
Note: TMP-SMX, Trimethoprim-sulfamethoxazole.